Page last updated: 2024-09-03

imatinib mesylate and Medulloblastoma

imatinib mesylate has been researched along with Medulloblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abouantoun, TJ; MacDonald, TJ	1

Other Studies

1 other study(ies) available for imatinib mesylate and Medulloblastoma

Article	Year
Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor. Molecular cancer therapeutics, 2009, Volume: 8, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Medulloblastoma; Neoplasm Invasiveness; Piperazines; PTEN Phosphohydrolase; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction	2009

Article

Year

Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor.

Molecular cancer therapeutics, 2009, Volume: 8, Issue:5

Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Medulloblastoma; Neoplasm Invasiveness; Piperazines; PTEN Phosphohydrolase; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction

2009